$AZN
Market Cap:
$AZN SEC Filings
| Filing | Filed On |
|---|---|
| FORM 6K | 28 Jul 2023 |
| ALEXION ENTERS GENE THERAPY AGREEMENT WITH PFIZER | 28 Jul 2023 |
| BEYFORTUS APPROVED IN US FOR INFANT RSV PREVENTION | 17 Jul 2023 |
| TOTAL VOTING RIGHTS | 03 Jul 2023 |
| DATO-DXD SIGNIFICANTLY IMPROVED PFS IN LUNG CANCER | 03 Jul 2023 |
| NIRSEVIMAB RECOMMENDED FOR INFANT RSV PROTECTION | 09 Jun 2023 |
| ASTRAZENECA AGREEMENT WITH QUELL THERAPEUTICS | 09 Jun 2023 |
| IMFINZI IMPROVED PCR IN GASTRIC AND GEJ CANCERS | 02 Jun 2023 |
| BLOCK LISTING INTERIM REVIEW | 01 Jun 2023 |
| TOTAL VOTING RIGHTS | 01 Jun 2023 |
| LYNPARZA APPROVED IN US FOR BRCAM PROSTATE CANCER | 01 Jun 2023 |
| IMFINZI + LYNPARZA PROLONGED PFS IN ENDOMETRIAL CANCER | 26 May 2023 |
| DIRECTORATE CHANGE | 22 May 2023 |
| TAGRISSO PLUS CHEMO IMPROVED PFS IN LUNG CANCER | 17 May 2023 |
| FARXIGA EXTENDED IN THE US FOR HEART FAILURE | 09 May 2023 |
| DIRECTOR/PDMR SHAREHOLDING | 09 May 2023 |
| TOTAL VOTING RIGHTS | 02 May 2023 |
| ODAC VOTE ON LYNPARZA COMBO IN PROSTATE CANCER | 02 May 2023 |
| DIRECTOR/PDMR SHAREHOLDING | 02 May 2023 |
| RESULT OF AGM | 27 Apr 2023 |
